Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Rick Wise has given his Buy rating due to a combination of factors including OrthoPediatrics' impressive fourth-quarter sales performance and strategic growth initiatives. The company recently reported fourth-quarter sales that surpassed expectations, growing by 40% year-over-year to $52.7 million, which was above both the company's and the Street's estimates. This strong performance was driven by significant growth in US revenues and the contribution from the Boston O&P acquisition.
Looking forward, OrthoPediatrics has set a conservative guidance for 2025, with the potential to exceed these initial targets as the year progresses due to upcoming product launches and a more stable operating environment. Although the initial sales and EBITDA guidance are slightly below consensus, the company's strategic positioning and growth catalysts suggest potential upside, supporting the Buy rating recommendation.
Wise covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Atricure, and Conmed. According to TipRanks, Wise has an average return of 4.2% and a 57.34% success rate on recommended stocks.
In another report released today, Needham also maintained a Buy rating on the stock with a $42.00 price target.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
OrthoPediatrics (KIDS) Company Description:
OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.